DNA variation and the future of human genetics

Nature Biotechnology
A J Schafer, J R Hawkins

Abstract

The use of DNA variants in the mapping of the human genome and in the positional cloning of monogenic disease genes is well established. Determining the genetic bases of the more common "multifactorial" diseases, however, presents a major challenge. The genetics of these diseases are complicated by the interplay between many genes and the environment. These investigations will require large numbers of DNA markers and the technology to screen large populations with these markers. The systematic identification of the common DNA polymorphisms in the human genome coupled with the development of high throughput screening methods should allow ultimately the elucidation of the genetic component of most clinical and nonclinical phenotypes.

References

Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·W L RussellE L Phipps
Jul 1, 1978·Annals of Human Genetics·B K SuarezT Reich
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R G RobertsD R Bentley
May 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·L E DelisiA Boccio
May 24, 1991·Science·S YuD Schlessinger
May 17, 1990·Nature·F YamamotoS Hakomori
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M OritaT Sekiya
Jan 1, 1985·Human Genetics·D N CooperJ Schmidtke
Mar 7, 1985·Nature·A J JeffreysS L Thein
Apr 28, 1973·Lancet·D A BrewertonR D Sturrock
Apr 5, 1973·The New England Journal of Medicine·L SchlossteinC M Pearson
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S G Fischer, L S Lerman
Jun 1, 1995·Current Opinion in Genetics & Development·D L Nelson
Apr 1, 1995·Nature Genetics·K J LivakJ A Todd
Apr 1, 1995·Nature Genetics·F S Collins
Sep 30, 1994·Science·E S Lander, N J Schork
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·A C PeaseS P Fodor
Oct 1, 1993·Nature Genetics·M Grompe
Jan 1, 1993·Human Mutation·K Hayashi, D W Yandell
Aug 1, 1993·Journal of Medical Genetics·M J Owen, P McGuffin
Jan 1, 1993·Analytical Biochemistry·F Khurshid, S Beck
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses
Jan 1, 1993·Human Molecular Genetics·J A NaylorF Giannelli
Dec 1, 1995·Trends in Genetics : TIG·H J Cordell, J A Todd
Dec 1, 1995·Trends in Genetics : TIG·D E Weeks, G M Lathrop
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·P A UnderhillL L Cavalli-Sforza
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·J Smith, P Modrich
May 14, 1996·Proceedings of the National Academy of Sciences of the United States of America·M T RoskeyL A Haff
Jan 1, 1996·Human Mutation·J M ShumakerC T Caskey
Jun 1, 1996·Current Opinion in Genetics & Development·R D Mashal, J Sklar
Dec 1, 1996·Nature Genetics
Dec 1, 1996·Nature Genetics·T D TaylorS J Hayflick
Feb 27, 1997·Nature·I WilmutK H Campbell

❮ Previous
Next ❯

Citations

Apr 11, 2009·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·Linghe ZengDeborah L Boykin
Jun 2, 2007·Analytical and Bioanalytical Chemistry·Yuki GotoKazuhiko Nakatani
Feb 13, 2001·Mutation Research·K Olden, J Guthrie
Jul 27, 2001·Mutation Research·W W Weber
Sep 25, 1999·Journal of Neuroimmunology·J ChatawayA Compston
Apr 6, 1999·Trends in Biotechnology·D J Graves
Feb 1, 2000·Trends in Biotechnology·T J Griffin, L M Smith
Jan 23, 1999·Current Opinion in Immunology·S Sawcer, P N Goodfellow
Dec 29, 1998·Molecular Medicine Today·J J GargusG A Gutman
Nov 2, 2001·Trends in Molecular Medicine·A J Brookes
Jul 1, 1999·The New England Journal of Medicine·F S Collins
Mar 24, 2006·New Genetics and Society·Herbert Gottweis
Oct 25, 2002·Journal of Women's Health & Gender-based Medicine·Marietta Anthony, Mary J Berg
Mar 21, 2001·EMBO Reports·W Martin, F Salamini
Mar 11, 2003·Nucleic Acids Research·Lars KaderaliP Scott White
Jul 24, 2002·Nucleic Acids Research·Heike A BehrensdorfAndreas Kappel
Oct 5, 2002·Nucleic Acids Research·Jörg TostIvo Glynne Gut
Jun 19, 2002·Alzheimer Disease and Associated Disorders·Zaven S Khachaturian
Jul 5, 2002·Genome Research·Leslie Y Y ChenMing-Jing Hwang
Nov 7, 2000·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·R R Sharp, M W Foster
Nov 20, 2003·Journal of Translational Medicine·Ping Jin, Ena Wang
Nov 7, 1998·Clinical Chemistry and Laboratory Medicine : CCLM·J Weissenbach
Mar 21, 2001·Pharmacogenomics·L ForsR W Kwiatkowski
Dec 21, 2011·Journal of Periodontology·Li-li ChenShu-mei Wang
Sep 10, 2008·Yi chuan = Hereditas·Ning LiJian-Guo Cheng
Jul 2, 2011·Pakistan Journal of Biological Sciences : PJBS·R Javed, Mukesh
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·P K ChatterjeeN S Shepherd
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·T J GriffinL M Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.